CEO Michael Demurjian discusses the importance of reformulated liquid oral suspension drugs, while outlining plans to launch a smart device that connects patients and doctors.
Month: January 2025
Aspargo Labs (AAGO) has filed to go public via a direct offering. The New York-based company, known for its liquid drug formulations and delivery devices, aims to list on the NYSE, with its lead product, a liquid sildenafil citrate formulation, approved in Europe.